Fujifilm Biotechnologies’ Holly Springs, North Carolina cell culture site was selected for the FDA’s PreCheck Pilot Program, a facility-inspection and engagement initiative intended to reduce uncertainty in manufacturing readiness. The program includes other major players and is designed to improve regulatory predictability and accelerate access to biologics by enabling earlier discussions with the agency.